Autorisation d’accès précoce refusée à la spécialité DUPIXENT (dupilumab).
See also
Décision d'accès précoce
16/11/2022
eNrdWNty2jAQfecrGL/L5hqcjiHT0qRlJplSEqadvjDCXoOokBxdCOnXV8akJR27SUT0khfG6LK7ks45u1J0tl3T+gaEJJz1vabf8OrAYp4Qtuh705sLFHpng1q0wht8MKznN/xmy6vHFEvZ9/Jefw6YSf/71eVHMPNBeINaPeLzFcTq0TitCPU/Y7m8wlk+ph5tOEnqa1BLnvS9TKtdaz2SSpgoBndc/JQZjiEK9i2HvatZ57A9CnJjz7CqJYhLzBalRoFZ2Yy1EMDUECtYcHFfajoTSXPWOg1PmqehlRMiJyC5FjGMsVqOBd+QBJJSXymmEqycpHfJNYgNBZU7KTUerOK1tDKOV3g7gdtRedDvTe9QbRVqoGave9ozW9VptTsnVq7EwVaVw8csIshm7XbYDcNOACxIICY5yhFDrUarhRrtXjdI4kDCGiUaNRuI8Q2s5wKKftMWc0phASgBRDFaYq0AmR8uiNo1SszMR8aFMh9IQKolShCOY5AoE4Yt8cNcmRnvmO7m6YxsDZosQTLOvVFH8CBy+BjqjvwIuH0ShgmRGcX3/kpmtluFBTbdIIwguVtIvoIbYSSSmj37xz7TlAYvjHq6FzBHEef6OOSaqQodu5jYbsSQGzZsq0/UTnrVdo9FAvL1zP7irDztjPWckthWW436aZBqOhlVS+ubVKUPWMJUuJOlb4Ql/E6+vtwdwstR9LuToE8UDd2uNZt/GCxX5NxzLXgGgRFCIo/RtxFL+bHKZuhRbuqBHG+PF7talMeYQkU1iizV1hDioXh2Rjl3dC46So1+Or+xxelXDeL+eve31DRJ+n8QZpeKXOQ3w4rKwF/OsUJq/ntPSeNZK+x1wrbdLUWLciVbKpXJd0GwxLIgmp+Kt5vuDkoddxc1J/VUUV8WKcNR6POiFng+TGwZ/1S1dewNYj9/f1Mp9aGEhiPOoUgOziR8dP76WeHv9cFZ2ONHKubOza7Ux8rIkavKT8/Ly76j8pA5V3YhjDh8SVNS8XpWicsoKF7uBrUoyF/tBrXf0a6k7w==
dc1UbffaneLVmBzC